JAGSNPHARM
Jagsnpharm
Live Price
₹215.00
-6.94-3.13%
Conviction Scorecard
AI Momentum
43%Technical Rating
41%Analyst Sentiment
85%Market News & Buzz
📰
Recent news and updates for JAGSNPHARM will appear here soon.
Stockmo Analyst Rationale
AI Generated Insight
"Balanced market signals for JAGSNPHARM. The stock is currently consolidating with neutral technical indicators and fundamental alignment between current healthcare growth rates and prevailing valuation metrics."
Verified by Stockmo Intelligence Grid
Supporting Evidence
Citing cross-referenced internal documents and market technicals
About Jagsnpharm
Jagsonpal Pharmaceuticals Limited engages in the manufacturing, selling, and trading of pharmaceutical products and active pharmaceutical ingredients in India and internationally. It offers pharmaceutical formulations and products in the areas of gynaecology, orthopaedics, dermatology, and paediatrics. The company provides drugs in the form of tablets, softgels, injections, capsules, and syrups. Jagsonpal Pharmaceuticals Limited was incorporated in 1978 and is based in Gurugram, India.
Frequently asked questions
As of the latest market session, Jagsnpharm (JAGSNPHARM) is trading at ₹215, representing a move of -3.13% from the previous close.
Jagsnpharm is listed and traded under the ticker symbol JAGSNPHARM on the National Stock Exchange of India (NSE) and Bombay Stock Exchange (BSE).
Today, Jagsnpharm's stock price moved by -3.13%. Long-term growth trends depend on company financials, technical moving averages, and sector momentum in the Healthcare industry.
Our proprietary AI Momentum engine calculates a 43% bullish probability for JAGSNPHARM stock over the next 3-5 days. View the live interactive chart on Stockmo to see dynamic technical forecasting.
Over the past 52 weeks, Jagsnpharm shares reached a high of ₹264.5 and hit a low of ₹155.
JAGSNPHARM exhibits standard volatility for a Healthcare stock, with an average daily trading volume of 33,166 shares. Detailed technical beta indicators are available on the Stockmo charting engine.
Jagsnpharm has a market capitalization of ₹1420.27 Cr, designating its size class inside the Healthcare sector.
Jagsnpharm has a current dividend yield of 108.00%. Companies may adjust payout ratios depending on quarterly earnings growth and reinvestment opportunities.
Jagsnpharm's trailing Price-to-Earnings (P/E) ratio is 32.23. This indicates how much investors are willing to pay for every rupee of the company's annual net earnings.
You can purchase Jagsnpharm (JAGSNPHARM) shares through any SEBI-registered stockbroker (such as Kite/Zerodha, Groww, or Angel One) by funding your trading account and executing a buy order on the NSE or BSE.
Jagsnpharm's financial health, solvency, growth, and quality metrics are tracked using our proprietary Multibagger V2 score. You can explore JAGSNPHARM's detailed 5-tier financial scorecard and compare it with market competitors on the Stockmo Multibagger Screener page.
Institutional order blocks and pristine support/resistance triggers for JAGSNPHARM are monitored in real-time. View live technical entry levels, stop loss bounds, and target prices on our interactive Supply & Demand Trading Engine or scan entire market segments using the Basket Scanner.
Jagsnpharm operates inside the Healthcare sector. You can analyze sector-wide trends, relative strengths, and locate top emerging leaders in this space using our Sector Analysis Hub.